Table 6.
Effect of additives and NE challenge on caecal SCFA profiles on d 21 (μmol/g)1.
| Item | UCC | NE challenged2 |
SEM | P-value | ||||
|---|---|---|---|---|---|---|---|---|
| CHC | BAC | SMP | SMF | SHM | ||||
| Formate | 6.12 | 4.17 | 3.89 | 3.67 | 4.17 | 6.52 | 1.22 | 0.417 |
| Acetate | 169a | 149c | 159abc | 155bc | 154bc | 163ab | 4 | 0.017 |
| Propionate | 4.72 | 3.66 | 4.27 | 4.45 | 3.82 | 4.59 | 0.31 | 0.098 |
| Isobutyrate | 1.17c | 1.57ab | 1.37bc | 1.56ab | 1.67ab | 1.78a | 0.13 | 0.019 |
| Butyrate | 51.1a | 35.4c | 42.8bc | 37.8c | 39.3bc | 46.9ab | 2.90 | 0.002 |
| Isovalerate | 1.84 | 2.61 | 2.59 | 2.88 | 2.01 | 2.02 | 0.74 | 0.897 |
| Valerate | 1.27 | 1.15 | 1.13 | 1.24 | 1.21 | 1.33 | 0.10 | 0.680 |
| Lactate | 2.40 | 2.73 | 3.05 | 3.50 | 3.42 | 3.07 | 0.29 | 0.076 |
| Succinate | 33.5 | 37.9 | 36.2 | 37.3 | 38.5 | 37.9 | 5 | 0.990 |
| Total SCFA | 272 | 238 | 254 | 247 | 248 | 267 | 9 | 0.066 |
NE = necrotic enteritis; SCFA = short-chain fatty acids.
a – c Values in a row with no common superscripts differ significantly (P < 0.05). Mean values are based on 2 birds per replicate and 13 replicates per treatment.
UCC, unchallenged control; CHC, challenged control; BAC, zinc bacitracin; SMP, a blend of short-chain fatty acids (SCFA), medium-chain fatty acids (MCFA) and phenolic compound; SMF, a blend of buffered SCFA with MCFA; SHM, a blend of buffered SCFA with a high concentration of MCFA.
NE challenged birds were gavaged with Eimeria spp. at d 9 and C. perfringens at d 14.